webo

In the competitive and innovative world of the biopharmaceutical industry, research and development (R&D) licensing is a critical strategy for companies aiming to expand their product pipelines, enhance innovation, and ultimately bring new treatments to market. Structuring a good R&D licensing deal involves careful consideration of various elements to ensure mutual benefit and long-term success […]

The importance of information transparency and parity between buyers and sellers cannot be overstated. Consider the ongoing debate in Congress over drug pricing – ignore for now the disregard Congress possesses for understanding the various and underlying causes for drug price inflation – and the political assertion that the biopharmaceutical industry is pillaging research funded

Pharmaceutical deal-making is a complex and multifaceted process, often fraught with challenges that can hinder progress and impact outcomes. From identifying the right assets to navigating regulatory landscapes, the journey is anything but straightforward. In this blog, we delve into some of the key challenges faced in pharma deal-making and explore strategies to overcome them.